Rietjens Judith A C, van der Heide Agnes, Vrakking Astrid M, Onwuteaka-Philipsen Bregje D, van der Maas Paul J, van der Wal Gerrit
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Ann Intern Med. 2004 Aug 3;141(3):178-85. doi: 10.7326/0003-4819-141-3-200408030-00006.
Terminal sedation in patients nearing death is an important issue related to end-of-life care.
To describe the practice of terminal sedation in the Netherlands.
Face-to-face interviews.
The Netherlands.
Nationwide stratified sample of 482 physicians; 410 responded and 211 of these reported characteristics of their most recent terminal sedation case.
Physician reports of frequency of terminal sedation (defined as the administration of drugs to keep the patient in deep sedation or coma until death, without giving artificial nutrition or hydration), characteristics of the decision-making process, drugs used, the estimated life-shortening effect, and frequency of euthanasia discussions.
Of respondents, 52% (95% CI, 48% to 57%) had ever used terminal sedation. Of the 211 most recent cases, physicians used terminal sedation to alleviate severe pain in 51% of patients (CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and dyspnea in 38% (CI, 32% to 45%). Physicians reported discussing with patients the decision to use deep sedation in 59% of the 211 most recent cases (CI, 52% to 66%) and the decision to forgo artificial nutrition or hydration in 34% (CI, 28% to 41%). Hastening death was partly the intention of the physician in 47% (CI, 41% to 54%) of cases and the explicit intention in 17% (CI, 13% to 22%) of cases.
The generalizability of physician reports about their most recent cases to all terminal sedation cases is uncertain. In addition, the findings are subject to recall bias and may not apply to other geographic settings.
Terminal sedation precedes a substantial number of deaths in the Netherlands. In about two thirds of most recently reported cases, physicians indicated that in addition to alleviating symptoms, they intended to hasten death.
临终患者的终末期镇静是与临终关怀相关的一个重要问题。
描述荷兰终末期镇静的实施情况。
面对面访谈。
荷兰。
482名医生的全国分层样本;410人作出回应,其中211人报告了其最近一例终末期镇静病例的特征。
医生报告的终末期镇静频率(定义为给予药物以使患者处于深度镇静或昏迷状态直至死亡,不给予人工营养或补液)、决策过程的特征、使用的药物、估计的缩短生命效果以及安乐死讨论的频率。
在作出回应的人中,52%(95%可信区间,48%至57%)曾使用终末期镇静。在211例最近的病例中,医生使用终末期镇静来缓解51%患者(可信区间,44%至58%)的剧痛、38%患者(可信区间,32%至45%)的躁动以及38%患者(可信区间,32%至45%)的呼吸困难。医生报告称,在211例最近的病例中,59%(可信区间,52%至66%)与患者讨论了使用深度镇静的决定,34%(可信区间,28%至41%)讨论了放弃人工营养或补液的决定。在47%(可信区间,41%至54%)的病例中,加速患者死亡在一定程度上是医生的意图,在17%(可信区间,13%至22%)的病例中是明确意图。
医生关于其最近病例的报告对所有终末期镇静病例的可推广性尚不确定。此外,研究结果存在回忆偏倚,可能不适用于其他地理区域。
在荷兰,大量死亡之前会实施终末期镇静。在最近报告的病例中,约三分之二的医生表示,除缓解症状外,他们还意图加速患者死亡。